Found 4 matching trials
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia
N/AThe purpose of this study is to estimate the incidence of Pure Red Cell Apl...
Location
MHAT "Dr. Tota Venkova"AD
Erythropoietin (EPO) to Protect Renal Function After Cardiac Surgery
PHASE2The purpose of this study is to evaluate the potential of erythropoietin in...
Location
Dept Thoracic Surgery, Anestesia and Intensive Care, SUS-Lund
Biosimilar Retacrit™ (Epoetin Zeta) in the Treatment of Chemotherapy-Induced Symptomatic Anaemia in Haematology and Oncology
N/AThe purpose of this study is to observe correction of haemoglobin (Hb) leve...
Location
Multiple Locations
Biological Predictive Factors of Response to ESA in Low Risk MDS Patients
PHASE4In this trial, the investigators would like to understand why a small perce...
Location
Multiple Locations